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Zika virus (ZIKV) and its infection are 
among the most recent significant viral 
security threats for global public health. 
ZIKV causes severe international concern 
due to its pandemic potential, economic 
burden, morbidity and mortality. ZIKV 
is a neurotropic, sexually transmitted 
Flavi virus and is a member of the Flavi­
viridae family, related to yellow fever, 
dengue (DEN), West Nile and Spondweni 
viruses. It is an enveloped virus with a 
single-strand positive sense RNA consist-
ing of a 10,794-nucleotide genome. As a 
mosquito-borne virus, ZIKV is transmit-
ted by many Aedes spp. mosquitoes, includ-
ing Aedes africanus, Aedes luteocephalus, 
Aedes hensilli, Aedes albopictus and Aedes 
aegypti [1]. ZIKV disease is a zoonotic 
arboviral nationally notifiable infection 
where human and nonhuman primates 
are the main reservoirs, and anthroponotic 
(human-to-vector-to-human) transmission 
may occur during outbreaks [2]. The viral 
transmission occurs through transfusion 
of infected blood, sexual intercourse and 
from infected mothers to their fetus during 
pregnancy. ZIKV is generally eliminated 
from the body after a few weeks although 
viral RNA may persist for longer periods 
in the semen after infection suggesting a 
high risk for sexual transmission [3]. Upon 
infection, ZIKV has been associated with 
congenital microcephaly, neurological 
complications including Guillain–Barré 
syndrome, meningoencephalitis and acute 
myelitis [4,5] and autoimmune complica-
tions [6]. Approximately 134 cases in Brazil 
have been confirmed to have microcephaly, 
and the remaining 2165 cases are under 
investigation [7].
ZIKV was first identified in rhesus 
macaque during sylvatic yellow fever sur-
veillance in the Zika Forest, Uganda, in 
1947 and was first reported in humans 
in 1952 [8]. Before 2006, only 14 cases 
of human ZIKV disease were reported, 
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including one case which was a laboratory-
acquired infection [9–13], and from 2007 to 
2016, the disease has been reported in more than 
40 countries. At the end of 2016, the number of 
Zika cases is escalating with an incidence rate of 
71.23% and with a total of 534,620 suspected 
cases, 176,239 confirmed cases, 5233 imported 
cases, 18 deaths and 2443 confirmed congenital 
syndromic cases in the Americas [14]. This sce-
nario triggered the US CDC and the NIH to 
declare that the ZIKV is at a ‘pandemic’ level, and 
the CDC issued a warning to pregnant women 
to avoid traveling to ZIKV-affected regions [2].
The Aedes species is widely distributed 
throughout the world, including Arab region 
countries and the Middle East. Among the 
routes available to the virus to cause a global 
pandemic and spread quickly to Asia, Africa 
and Europe, it is through the annual gather-
ing in Mecca where more than two million of 
Muslims gather from across the globe. Here, 
we discuss the potential routes which could 
be responsible for the global Zika pandemic, 
and strategies of governmental health officials, 
the WHO and the public could adopt to limit 
spread of the virus.
Potential routes for global ZiKV pandemic
The increased connectedness of populations 
across the globe creates favorable conditions 
for the rapid transmission of new emerging 
diseases such as ZIKV disease. The Kingdom 
of Saudi Arabia issues millions of visas for 
Muslims coming from all over the world for 
practicing Umrah (pilgrimage to Holy Mecca, 
which may be performed by Muslims at any 
time of the year). The Hajj (annual pilgrim-
age, which is performed by Muslims only once 
a year at specific time) is an ongoing annual 
gathering event. In this annual spiritual gather-
ing, more than a million of pilgrims visit the 
holy locations in Mecca, Saudi Arabia. This 
gathering includes Muslims from across the 
globe, including South Americans, Europeans 
and Asians. In addition to this, a significant 
number of the expatriate workers from South 
America, Africa and Asia who reside in Saudi 
Arabia, Qatar, Bahrain, Kuwait, Oman and 
United Arab Emirates annually visit their 
home countries. A silent reservoir of ZIKV 
in Arab countries, Asia and Africa could be 
immunologically naive individuals who do 
not have adequate knowledge about the mode 
of transmission or who are not able to protect 
themselves from ZIKV. There are a few factors 
that are favorable to help spread ZIKV during 
Umrah and Hajj seasons, including elevated cli-
matic temperatures, which may exceed 100°F, 
and sexual transmission. Earlier and recent 
reports of ZIKV through male sex partner 
semen from Florence (Italy) and Dallas (Texas, 
USA) made the CDC declare ZIKV disease as 
sexually transmitted disease [15,16]. The CDC 
has advised travelers from infected countries 
to use condoms or to avoid sexual contact with 
the infected males [17]. These gathering events 
could be the nuclei for infectious and commu-
nicable disease transmission. Therefore, special 
attention must be given to individuals taking 
part in these events to limit the spread of ZIKV 
disease and avoid the  looming risk of a global 
pandemic.
There are plenty of potential niches in the 
Middle East and North African countries 
where the Aedes species mosquito could find 
fertile environ ments to breed, such as in stag-
nant water of uncovered containers, toilet tanks, 
flower vases, buckets and discarded bags. In 
addition, wet areas around air-conditioning sys-
tems, which are commonly used in Saudi Arabia 
and other Gulf countries and in Asia due to the 
hot climate, may be potential breeding areas. 
Mosquitoes gather around these environments 
representing high risk for transmission of ZIKV 
as well as DEN viruses.
Therefore, raising awareness about the spread 
of the disease should be a priority, and warnings 
need to be officially issued to the areas where 
the virus has reached the pandemic level. These 
areas should also be cautiously monitored for all 
incoming travelers, whether they are domestic 
or international travelers. Several methods could 
be used to provide protection to the pilgrims in 
the Hajj season, including installing ovitraps 
to monitor insects that are known to transmit 
ZIKV, the use of barriers like screens, closed 
doors and windows, the use of mosquito nets 
and spraying or fogging with insecticides in areas 
that are suspected of the presence of the Aedes 
mosquito.
There are little data available on the range 
of zoonoses circulating in the Middle East and 
North African countries. This includes a lack of 
knowledge on the presence of medically impor-
tant arthropod vectors, while endemicity for a 
range of zoonoses is based on knowledge from 
other countries in the Arabian Peninsula with 
similar climatic and socioeconomic conditions. 
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More importantly, the increasing demand for 
expatriates and livestock is expected to increase 
in the coming years due to increasing labor 
requirements in urbanization, among others 
related to the infrastructure needed for the 
World Championships Soccer in Qatar 2022. 
These increasing requirements will continue 
with escalating risks for the introduction of 
arboviruses including ZIKV vectors into the 
region. In addition, the championships will 
attract visitors from different global regions 
including ZIKV-affected areas such as Central 
and South America, the Caribbean, Asia and 
Africa, imposing an additional demand on the 
public health systems.
Climate changes create favorable conditions 
for the establishment of disease vectors, such as 
Aedes spp., in new geographic regions supporting 
local transmission of ZIKV. The perturbation 
between ecological balances, including global 
climate changes and increased inter national 
travel, helps spread of ZIKV. The majority of 
emerging infectious diseases are zoonotic such 
as ZIKV infection with the involvement of wild-
life, which may have serious effects on human 
health. Humans, animals and the environment 
are interconnected and will have multidirec-
tional impact on each other. Surveillance for 
viral pathogens and vector-borne infections 
in animal species and wildlife are imperative 
intervention measures that will help reduce 
and control the spread of emerging arboviruses 
including ZIKV.
Conclusion & future perspective
Although ZIKV is known to circulate in Africa, 
the Americas and Asia, there is uncertainty as 
to what the pandemic level it is expected to 
reach and what the actual risks of the virus are 
to endanger human health in the absence of 
licensed vaccines and specific effective antiviral 
agents. Therefore, it is of great importance to 
conduct regular surveillance on ZIKV disease 
among domestic travelers coming or known 
to be in contact with people from epidemic 
and infected areas. This can be quickly per-
formed using sensitive molecular diagnostic 
techniques such as conventional or real-time 
reverse transcription PCR to investigate early 
infection and detect viral RNA in body flu-
ids such as urine, cerebrospinal fluid, semen 
or serum [2]. Concerted global and national 
efforts to tackle the disease should be advo-
cated in ZIKV-affected regions as well as in 
other high-risk countries. This is important 
since one in five people infected with ZIKV 
become symptomatic, and most cases (about 
80%) are asymptomatic with a self-limiting 
febrile illness [18]. Serological techniques 
detecting virus-specific anti-ZIKV IgM pro-
vide timely prenatal intervention to infected 
pregnant women. These approaches will ensure 
that the virus is contained and will avoid fur-
ther spread of the virus. However, these efforts 
cannot be achieved without concerted efforts 
from individual cooperations among the 
govern mental health authorities and inter-
national organizations, such as the WHO, 
to work hand in hand in order to avoid the 
spread of this disease and save lives now and 
in the future. To date, there are no clinically 
approved vaccines available for the prophylaxis 
against ZIKV infection as well as many other 
flaviviruses. In addition, there is no specific 
chemotherapeutic antiviral agent currently 
available for treatment. There are two DNA 
vaccines against ZIKV that are under develop-
ment in clinical trial phases [19], although there 
are no DNA vaccines yet available for clini-
cal use in humans against any infectious dis-
ease. Therefore, further epidemiological and 
control studies are critical to implement the 
most appropriate prevention measures which 
are crucial to reduce the incidence of infec-
tion and will reduce transmission. The use of 
insecticides and mosquito repellent is impor-
tant but should be regulated to avoid spread of 
resistance. The recent use and application of 
biological control measures such as Wolbachia 
in reducing transmission of dengue virus could 
pave the way for use in ZIKV transmission 
reduction as well [20–23]. More research studies 
are required to investigate the use and benefits 
of biological control measures and search for 
additional biological control agents against 
ZIKV to combat arboviral spread in parallel 
to ZIKV vaccine initiatives.
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